| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |